Market revenue in 2023 | USD 678.6 million |
Market revenue in 2030 | USD 940.4 million |
Growth rate | 4.8% (CAGR from 2023 to 2030) |
Largest segment | Transthoracic echocardiography |
Fastest growing segment | Fetal Echocardiography |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transthoracic Echocardiography, Transesophageal Echocardiography, Fetal Echocardiography, Other Types |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Koninklijke Philips NV, Siemens Healthineers AG ADR, Hitachi Ltd, shenzhen mindray automation equipment co., FUJIFILM Holdings Corp, Samsung Medison, Chison Medical Technologies |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiovascular ultrasound market will help companies and investors design strategic landscapes.
Transthoracic echocardiography was the largest segment with a revenue share of 55.38% in 2023. Horizon Databook has segmented the U.S. cardiovascular ultrasound market based on transthoracic echocardiography, transesophageal echocardiography, fetal echocardiography, other types covering the revenue growth of each sub-segment from 2018 to 2030.
According to CDC, around 735,000 Americans have a heart attack every year, out of which 525,000 people experience it for the first time and the rest 210,000 occur in people who have already had an attack. This highlights the scope for growth of CVUS equipment.
The highest usage of echocardiography in hospitals is observed along the east coast of the U.S. When evaluated on a state-by-state basis, New York, Rhode Island, and Montana were major users of inpatient echo technology, whereas Wyoming, Alaska, and New Mexico had the lowest rate.
For instance, in August 2020, Philips launched EPIQ CVx cardiovascular ultrasound system. This CVUS is built on the EPIQ ultrasound platform, which helps in increasing diagnostic confidence and simplifies clinicians workflow. It also helps in providing accurate information without frequent monitoring, thereby reducing the need for repeat scans.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. cardiovascular ultrasound market , including forecasts for subscribers. This country databook contains high-level insights into U.S. cardiovascular ultrasound market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account